Endothelial arginase II and atherosclerosis
Atherosclerotic vascular disease is the leading cause of morbidity and mortality in developed countries. While it is a complex condition resulting from numerous genetic and environmental factors, it is well recognized that oxidized low-density lipoprotein produces pro-atherogenic effects in endothel...
Main Authors: | Sungwoo Ryoo, Dan E. Berkowitz, Hyun Kyo Lim |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Anesthesiologists
2011-07-01
|
Series: | Korean Journal of Anesthesiology |
Subjects: | |
Online Access: | http://ekja.org/upload/pdf/kjae-61-3.pdf |
Similar Items
-
Role of arginase in vessel wall remodeling
by: William eDurante
Published: (2013-05-01) -
p32-Dependent p38 MAPK Activation by Arginase II Downregulation Contributes to Endothelial Nitric Oxide Synthase Activation in HUVECs
by: Bon-Hyeock Koo, et al.
Published: (2020-02-01) -
Elderberry extract improves molecular markers of endothelial dysfunction linked to atherosclerosis
by: Joseph Festa, et al.
Published: (2023-07-01) -
PHARMACOLOGICAL EFFICACY OF AN INHIBITOR OF ARGINASE-2 KUD975 WITH L-NAME-INDUCED ENDOTHELIAL DYSFUNCTION
by: Konstantin Kudryavtsev, et al.
Published: (2017-03-01) -
Methylglyoxal-Modified Albumin Effects on Endothelial Arginase Enzyme and Vascular Function
by: Ebaa M. Alzayadneh, et al.
Published: (2023-03-01)